Merck & Co Inc
Trump tariff fallout: Some industries grapple with lingering effects one year later
A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off a wave of economic and political uncertainty, some companies are still feeling the effects. While some industries have emerged largely unscathed — having weathered twists and turns of several tariff iterations — others, such as retail, automotive, […]
Read More
Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs
The Trump administration is preparing to impose new tariffs on branded drugs from pharmaceutical companies that have not struck landmark deals with the president to lower their U.S. drug prices, CNBC has learned. Patented medications and their active ingredients would be hit with a 100% tariff, according to a draft of the document obtained by […]
Read More
Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week
A sign of Swiss pharmaceutical giant Novartis is seen on the top of a building at Novartis Campus in Basel, northern Switzerland, on Sept. 9, 2025. Fabrice Coffrini | AFP | Getty Images Novartis is planning to buy U.S.-based biotech Excellergy for up to $2 billion, betting on a next-generation allergy treatment that may prove […]
Read More
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline
Pharma giant Merck is buying U.S. biotech firm Terns Pharmaceuticals for $6.7 billion to boost its oncology pipeline, the company said Wednesday. This is the third multibillion-dollar acquisition for Merck over the past year as the company looks to bulk up its portfolio before its best-selling cancer drug Keytruda loses key patent protection in 2028. […]
Read More
U.S.-Iran negotiations, Meta trial verdict, OpenAI shuts Sora and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Wednesday. I spent yesterday evening at a market technicals event and then went to watch the “Hannah Montana 20th Anniversary Special.” You might call it the best of both worlds. Stock futures are up this morning after a losing day. Here […]
Read More
Stocks making the biggest moves premarket: Chewy, EchoStar, Arm, KB Home & more
Check out the companies making the biggest moves premarket: CF Industries — The fertilizer manufacturer and distributor fell nearly 4% as reports on negotiations surrounding the U.S.-Iran war signaled the commodity’s shortage could end. Fertilizer prices have soared since the closure of the Strait of Hormuz, sending shares of CF Industries up more than 27% […]
Read More
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide
The U.S. and Israel are showing signs of escalating their war against Iran – a move that could batter a variety of assets, even traditional safe havens. To protect their portfolios, investors can snap up stocks from an oft-shorted sector: pharmaceuticals, UBS analysts say. Since the first strikes last Saturday, the Iran War has roiled […]
Read More
European markets open lower as Iran war unsettles traders
U.S. President Donald Trump speaks during a roundtable meeting on the administration’s “ratepayer protection pledge” in the Indian Treaty Room at the White House on March 4, 2026 in Washington, DC. Win McNamee | Getty Images LONDON — European stocks were in the red again on Thursday as market participants followed geopolitical developments in the […]
Read More
Russia’s war on Ukraine puts women off having children — and that could spell economic disaster
A woman carries a baby as she reacts after evacuating from Russian troop-occupied Kupiansk town in a bus convoy, amid Russia’s attack on Ukraine, on the outskirts of Kharkiv, Ukraine May 30, 2022. Picture taken May 30, 2022. Ivan Alvarado | Reuters Four years of war between Russia and Ukraine are beginning to take their […]
Read More
Jim Cramer’s top 10 things to watch in the stock market Friday
My top 10 things to watch Friday, Feb. 20 1. Blue Owl Capital’s loan sales, part of a plan to return capital to investors, has observers bringing out “canary in the coal mine” warnings again. While many private credit loans seem mismarked, this situation doesn’t appear tragic in nature. 2. Stock futures were lower after […]
Read More